|
Register
by February 15, 2008 and Save up to $400
ENROLLMENT OBJECTIVES MET
POSITIVE RESULTS
WINNING STRATEGIES
Conference Coverage Includes:
-
Marketing Outside the US?: Specific Requirements to be Aware of
-
Enrolling Patients Outside the US?: What You Need to Assess
-
Identification and Selection of Investigators
-
Maximization of Patient Recruitment and Enrollment
-
Benchmarking: Are You Achieving Your Recruitment Goals
-
Planning for Recruitment with Adaptive Trial Designs
-
Recruitment of Special Populations
-
Enhancing Patient Compliance and Retention
Who Should Attend: If you have a responsibility in any of the following areas, this is a must event for you in 2008
|
Patient Recruitment in Clinical Trials |
|
|
Restoring Public Trust in Clinical Research through Outreach and Education
 Kenneth A. Getz, M.S., Senior Research Fellow, Center for the Study of Drug Development, Tufts University
This presentation will: 1) Review the current state of public distrust in the clinical research enterprise 2) Assess the impact of public distrust on patient recruitment and retention effectiveness 3) Examine the root causes of the erosion of trust 4) Discuss new strategies to restore public trust 5) Evaluate how well these strategies are working to date. |
|
Key Issues With Patient Recruitment Today
Diana L. Anderson, Ph.D., President and CEO, D. L. Anderson International, Inc.
The Development of a Global Clinical Program Enrollment Strategy
Melissa Marshall, MS, Assistant Director, Global Enrollment Planning and Performance, Wyeth Research
Leveraging Opted-In Patient Databases for Centralized Patient Recruitment
Bruce Gould, M.B.A., Acurian Inc.
Recruiting Participants with Advanced Life-Limiting Illness
Amy Abernethy, M.D., Assistant Professor, Medicine/Oncology, Duke University Medical Center
The Benefits of Centralized Recruitment: Metrics and Case Studies
Donna Beasley, Vice President Operations, Praxis
Utilizing in House Expertise and Resources to Enhance Enrollment at the Clinical Sites
Chris Marrone, Pharm D, Medical Liasion Oncology, Eli Lilly and Company
Addressing the Challenges of Recruiting for Alzheimer s Disease Studies,
Paula Moore, Director, Clinical Trials, Medical Science, Alzheimer’s Association
|
